Revenue, 2025
USD 7.39
Forecast Year, 2034
USD 17.93 Bn
CAGR, 2025 - 2034
10.35%
Report Coverage
Worldwide
The global melanoma therapeutics market, valued at USD 7.39B in 2025, is projected to reach USD 17.93B by 2034, growing at a CAGR of 10.35%, driven by rising prevalence, innovative therapies, and enhanced treatment adoption worldwide.
Melanoma Therapeutics Market Size Analysis
Melanoma Therapeutics Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy | 0.75 | 0.81 | 0.90 | 0.99 | 1.10 | 1.21 | 1.34 | 1.49 | 1.62 | 1.80 |
| Immunotherapy | 1.48 | 1.64 | 1.81 | 1.99 | 2.20 | 2.42 | 2.68 | 2.94 | 3.25 | 3.58 |
| Targeted Therapy | 2.22 | 2.45 | 2.70 | 2.98 | 3.29 | 3.63 | 4.00 | 4.41 | 4.89 | 5.38 |
| Radiation Therapy | 2.94 | 3.26 | 3.59 | 3.97 | 4.37 | 4.83 | 5.33 | 5.89 | 6.49 | 7.17 |
Melanoma Therapeutics Market Size By Drug Type 2025 to 2034 (USD Billion)
| Drug Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Branded Drugs | 2.47 | 2.74 | 3.00 | 3.32 | 3.68 | 4.04 | 4.47 | 4.93 | 5.43 | 6.00 |
| Generic Drugs | 4.92 | 5.41 | 6.00 | 6.61 | 7.28 | 8.05 | 8.87 | 9.79 | 10.82 | 11.93 |
Melanoma Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.74 | 0.82 | 0.90 | 0.99 | 1.10 | 1.23 | 1.34 | 1.47 | 1.62 | 1.80 |
| LAMEA | 1.48 | 1.64 | 1.81 | 1.99 | 2.19 | 2.41 | 2.67 | 2.94 | 3.26 | 3.59 |
| Europe | 2.21 | 2.44 | 2.69 | 2.98 | 3.29 | 3.62 | 3.99 | 4.42 | 4.87 | 5.38 |
| Asia-Pacific | 2.95 | 3.26 | 3.60 | 3.97 | 4.37 | 4.83 | 5.34 | 5.89 | 6.50 | 7.17 |
Melanoma Therapeutics Market Size to Hit USD 17.93 Billion by 2034
The global melanoma therapeutics market size is calculated at USD 7.39 billion in 2025 and is predicted to attain around USD 17.93 billion by 2034 with a expanding at a CAGR of 10.35%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com